BLOG

Novel drug prevents common viral disease in stem-cell transplant patients … – Medical Xpress

Novel drug prevents common viral disease in stem–cell transplant patients …Medical XpressA new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital indicates. …read more   &nbs… Continue reading

2013-09-25 NEWS

Canadian stem cell technology expected to offer new options for blood stem … – Canada NewsWire (press release)

Canadian stem cell technology expected to offer new options for blood stem …Canada NewsWire (press release)OTTAWA, Sept. 25, 2013 /CNW/ – A Canadian technology that has the potential to boost the number of stem cells given to patients undergoing transplants of the blood-forming system has been recognized as the most impactful stem cell research paper … Continue reading

2013-09-25 NEWS

International Stem Cell Corporation to Present New Data From Parkinson’s … – Marketwired (press release)

International Stem Cell Corporation to Present New Data From Parkinson’s …Marketwired (press release)CARLSBAD, CA–(Marketwired – Sep 25, 2013) – International Stem Cell Corporation ( OTCQB : ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies, announced today that its chief … …read more   &nbs… Continue reading

2013-09-25 NEWS

International Stem Cell Corporation to Present New Data From Parkinson’s … – MENAFN.COM

International Stem Cell Corporation to Present New Data From Parkinson’s …MENAFN.COMCARLSBAD, CA, Sep 25, 2013 (Menafn – Marketwired via COMTEX) –International Stem Cell Corporation (otcqb:ISCO)(www.internationalstemcell.com), a California-based biotechnologycompany developing novel stem cell based therapies, announced … and more …read more   &nbs… Continue reading

2013-09-25 NEWS

Bioheart, Invitrx sign licensing agreement for adipose derived stem cells – Pharmaceutical Business Review

Bioheart, Invitrx sign licensing agreement for adipose derived stem cellsPharmaceutical Business ReviewInvitrx Therapeutics specializes in the culture and engineering of adult stem cells, new products and therapies that are used in aesthetics, wound closure, and healing, as well as plastic and reconstructive surgery. Since 10 years, Invitrx team has … …read more   &nbs… Continue reading

2013-09-25 NEWS